Evidence method
Sequential · gp.financial.deposits
-0.60% · CORE · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
SBFG · Dec 31, 2024
SB FINANCIAL GROUP, INC.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001213900-25-021622Bank
Evidence method
Yoy · gp.fundamentals.net_income
-5.17% · CORE · VALID
Evidence method
Level · gp.fundamentals.cash
$25.9M · CORE · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History56 statesSelf-history eligible
Sep 30, 20206/6 normalizedLevel 3Dec 31, 20206/6 normalizedLevel 3Mar 31, 20216/6 normalizedLevel 3Jun 30, 20216/6 normalizedLevel 3Sep 30, 20216/6 normalizedLevel 3Dec 31, 20216/6 normalizedLevel 3Mar 31, 20226/6 normalizedLevel 3Jun 30, 20226/6 normalizedLevel 3Sep 30, 20226/6 normalizedLevel 3Dec 31, 20226/6 normalizedLevel 3Mar 31, 20236/6 normalizedLevel 3Jun 30, 20236/6 normalizedLevel 3Sep 30, 20235/5 normalizedLevel 3Dec 31, 20234/4 normalizedLevel 3Sep 30, 20243/3 normalizedLevel 3Dec 31, 20243/3 normalizedLevel 3Sep 30, 20253/3 normalizedLevel 3Dec 31, 20253/3 normalizedLevel 3Mar 31, 20263/3 normalizedLevel 3Jun 30, 20263/3 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 8.35%
- Current
- -0.60%
- Delta
- -8.94%
- Previous
- -12.39%
- Current
- -5.17%
- Delta
- 7.23%
- Previous
- $49.3M
- Current
- $25.9M
- Delta
- -$23.4M
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.